Concepedia

3500 ORAL Preliminary results from a phase II, randomized, double-blind study of sorafenib plus doxorubicin versus placebo plus doxorubicin in patients with advanced hepatocellular carcinoma

Ghassan K Abou Alfa, Peter Johnson, Jennifer J. Knox, J. Lacava, To‐Wai Leung, Aroka Mori, Marine Leberre, D. Voliotis, Leonard B. Saltz

European Journal of Cancer Supplements · 2007 · 56 citations · 0 references

DOI

Concepts